Top Markets
#1 TENDIES TENDIES +54.24%
#2 Threshold Network Threshold Network +54.06%
#3 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#4 OSK OSK +16.47%
#5 Kinetiq Kinetiq +15.86%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Kite Kite +12.06%
#8 Maple Finance Maple Finance +12.00%
#9 Mubarak Mubarak +11.90%
#10 Magma Finance Magma Finance +11.37%
Coin of the day
TENDIES TENDIES
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rangering i aksjer #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Aksjekurs
$1.38
Markedsverdi
$255.69M
Endring (1 dag)
3.76%
Endring (1 år)
-20.69%
Land
US
Handel Neumora Therapeutics, Inc. Common Stock (NMRA)

Kategori

Healthcare
Aksjeprishistorikk for Neumora Therapeutics, Inc. Common Stock (NMRA)
Høyeste sluttskurs: $1.35 den 2026-09-01

Laveste sluttskurs: $12.50 den 2023-09-01
Aksjeprishistorikk for Neumora Therapeutics, Inc. Common Stock fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.65 37.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.27%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.50 513.89%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $763.69 9.05%
CH